Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Capital Expenditures (2016 - 2026)

Healthequity (HQY) has 13 years of Capital Expenditures data on record, last reported at -$24.8 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 297.45% year-over-year to -$24.8 million; the TTM value through Oct 2025 reached -$34.2 million, down 143.3%, while the annual FY2025 figure was $2.1 million, 94.93% down from the prior year.
  • Capital Expenditures reached -$24.8 million in Q4 2025 per HQY's latest filing, down from $26.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $55.4 million in Q1 2022 and bottomed at -$35.8 million in Q1 2025.
  • Average Capital Expenditures over 5 years is $7.6 million, with a median of $743000.0 recorded in 2021.
  • The widest YoY moves for Capital Expenditures: up 791871.43% in 2022, down 2657.6% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $6.9 million in 2021, then surged by 375.27% to $32.9 million in 2022, then tumbled by 101.49% to -$492000.0 in 2023, then skyrocketed by 2655.08% to $12.6 million in 2024, then plummeted by 297.45% to -$24.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$24.8 million in Q4 2025, $26.4 million in Q3 2025, and $86000.0 in Q2 2025.